Matthew W. Keller

Matthew W. Keller

Auto-generated profile, based on publicly available information

Matthew W. Keller

Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, USA

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 February 2021 in Nature
Verified
Journal Article
Closed access
PDF file
BZBin Zhou
Bin Zhou
TTTran Thi Nhu Thao
Tran Thi Nhu Thao
DHDonata Hoffmann
Donata Hoffmann
ATAdriano Taddeo
Adriano Taddeo
NENadine Ebert
Nadine Ebert
MBMartin Beer
Martin Beer

7 February 2022 in Nature Medicine
Verified
Journal Article
Open access
PDF file
NWNicole L. Welch
Nicole L. Welch
MZMeilin Zhu
Meilin Zhu
CHCatherine Hua
Catherine Hua
JWJuliane Weller
Juliane Weller
MMMarzieh Ezzaty Mirhashemi
Marzieh Ezzaty Mirhashemi
CMCameron Myhrvold
Cameron Myhrvold
The coronavirus disease 2019 (COVID-19) pandemic has demonstrated a clear need for high-throughput, multiplexed and sensitive assays for detecting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and other respiratory viruses and their emerging variants. Here, we present a cost-effective virus and variant detection platform, called microfluidic Combinatorial Arrayed Reactions for Multiplexed Evaluation of Nucleic acids (mCARMEN), which combines CRISPR-based diagnostics and microfluidics with a streamlined workflow for clinical use. We developed the mCARMEN respiratory virus panel to test for up to 21 viruses, including SARS-CoV-2, other coronaviruses and both influenza strains, and demonstrated its diagnostic-grade performance on 525 patient specimens in an academic setting and 166 specimens in a clinical setting. We further developed an mCARMEN panel to enable the identification of 6 SARS-CoV-2 variant lineages, including Delta and Omicron, and evaluated it on 2,088 patient specimens with near-perfect concordance to sequencing-based variant classification. Lastly, we implemented a combined Cas13 and Cas12 approach that enables quantitative measurement of SARS-CoV-2 and influenza A viral copies in samples. The mCARMEN platform enables high-throughput surveillance of multiple viruses and variants simultaneously, enabling rapid detection of SARS-CoV-2 variants.

5 November 2015 in Frontiers in Microbiology
Verified
Journal Article
Open access
BZBenjamin M. Zeldes
Benjamin M. Zeldes
MKMatthew W. Keller
Matthew W. Keller
ALAndrew J. Loder
Andrew J. Loder
CSChristopher T. Straub
Christopher T. Straub
MAMichael W. W. Adams
Michael W. W. Adams
RKRobert M. Kelly
Robert M. Kelly
Enzymes from extremely thermophilic microorganisms have been of technological interest for some time because of their ability to catalyze reactions of industrial significance at elevated temperatures. Thermophilic enzymes are now routinely produced in recombinant mesophilic hosts for use as discrete biocatalysts. Genome and metagenome sequence data for extreme thermophiles provide useful information for putative biocatalysts for a wide range of biotransformations, albeit involving at most a few enzymatic steps. However, in the past several years, unprecedented progress has been made in establishing molecular genetics tools for extreme thermophiles to the point that the use of these microorganisms as metabolic engineering platforms has become possible. While in its early days, complex metabolic pathways have been altered or engineered into recombinant extreme thermophiles, such that the production of fuels and chemicals at elevated temperatures has become possible. Not only does this expand the thermal range for industrial biotechnology, it also potentially provides biodiverse options for specific biotransformations unique to these microorganisms. The list of extreme thermophiles growing optimally between 70 and 100°C with genetic toolkits currently available includes archaea and bacteria, aerobes and anaerobes, coming from genera such as Caldicellulosiruptor, Sulfolobus, Thermotoga, Thermococcus and Pyrococcus. These organisms exhibit unusual and potentially useful native metabolic capabilities, including cellulose degradation, metal solubilization, and RuBisCO-free carbon fixation. Those looking to design a thermal bioprocess now have a host of potential candidates to choose from, each with its own advantages and challenges that will influence its appropriateness for specific applications. Here, the issues and opportunities for extremely thermophilic metabolic engineering platforms are considered with an eye towards potential technological advantages for high temperature industrial biotechnology.

26 September 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MKMatthew W. Keller
Matthew W. Keller
BRBenjamin L. Rambo-Martin
Benjamin L. Rambo-Martin
MWMalania M. Wilson
Malania M. Wilson
CRCallie A. Ridenour
Callie A. Ridenour
SSSamuel S. Shepard
Samuel S. Shepard
JBJohn R. Barnes
John R. Barnes
For the first time, a coding complete genome of an RNA virus has been sequenced in its original form. Previously, RNA was sequenced by the chemical degradation of radiolabeled RNA, a difficult method that produced only short sequences. Instead, RNA has usually been sequenced indirectly by copying it into cDNA, which is often amplified to dsDNA by PCR and subsequently analyzed using a variety of DNA sequencing methods. We designed an adapter to short highly conserved termini of the influenza A virus genome to target the (-) sense RNA into a protein nanopore on the Oxford Nanopore MinION sequencing platform. Utilizing this method with total RNA extracted from the allantoic fluid of influenza rA/Puerto Rico/8/1934 (H1N1) virus infected chicken eggs (EID50 6.8 × 109), we demonstrate successful sequencing of the coding complete influenza A virus genome with 100% nucleotide coverage, 99% consensus identity, and 99% of reads mapped to influenza A virus. By utilizing the same methodology one can redesign the adapter in order to expand the targets to include viral mRNA and (+) sense cRNA, which are essential to the viral life cycle, or other pathogens. This approach also has the potential to identify and quantify splice variants and base modifications, which are not practically measurable with current methods.

25 March 2013 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
MKMatthew W. Keller
Matthew W. Keller
GSGerrit J. Schut
Gerrit J. Schut
GLGina L. Lipscomb
Gina L. Lipscomb
AMAngeli L. Menon
Angeli L. Menon
IIIfeyinwa J. Iwuchukwu
Ifeyinwa J. Iwuchukwu
MAMichael Adams
Michael Adams
Microorganisms can be engineered to produce useful products, including chemicals and fuels from sugars derived from renewable feedstocks, such as plant biomass. An alternative method is to use low potential reducing power from nonbiomass sources, such as hydrogen gas or electricity, to reduce carbon dioxide directly into products. This approach circumvents the overall low efficiency of photosynthesis and the production of sugar intermediates. Although significant advances have been made in manipulating microorganisms to produce useful products from organic substrates, engineering them to use carbon dioxide and hydrogen gas has not been reported. Herein, we describe a unique temperature-dependent approach that confers on a microorganism (the archaeon Pyrococcus furiosus, which grows optimally on carbohydrates at 100°C) the capacity to use carbon dioxide, a reaction that it does not accomplish naturally. This was achieved by the heterologous expression of five genes of the carbon fixation cycle of the archaeon Metallosphaera sedula, which grows autotrophically at 73°C. The engineered P. furiosus strain is able to use hydrogen gas and incorporate carbon dioxide into 3-hydroxypropionic acid, one of the top 12 industrial chemical building blocks. The reaction can be accomplished by cell-free extracts and by whole cells of the recombinant P. furiosus strain. Moreover, it is carried out some 30°C below the optimal growth temperature of the organism in conditions that support only minimal growth but maintain sufficient metabolic activity to sustain the production of 3-hydroxypropionate. The approach described here can be expanded to produce important organic chemicals, all through biological activation of carbon dioxide.

1 January 2011 in Metallomics
Verified
Journal Article
Open access
PDF file
JRJeffrey T. Rubino
Jeffrey T. Rubino
MCMichael P. Chenkin
Michael P. Chenkin
MKMatthew Keller
Matthew Keller
PRPamela Riggs-Gelasco
Pamela Riggs-Gelasco
KFKatherine J Franz
Katherine J Franz
The N-terminal, extracellular regions of eukaryotic high affinity copper transport (Ctr) proteins vary in composition of the Cu(i) binding amino acids